Invesco PureBeta MSCI USA ETF Stock Forecast, Price & News

Wall Street analysts have given Invesco PureBeta MSCI USA ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Invesco PureBeta MSCI USA ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Invesco PureBeta MSCI USA ETF's stock was trading at $27.31 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PBUS shares have increased by 58.6% and is now trading at $43.32.
View which stocks have been most impacted by COVID-19.

Invesco PureBeta MSCI USA ETF trades on the BATS under the ticker symbol "PBUS."

Invesco PureBeta MSCI USA ETF's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include National Pension Service (0.00%), Jacobi Capital Management LLC (0.00%) and AdvisorNet Financial Inc (0.00%).

PBUS stock was sold by a variety of institutional investors in the last quarter, including Jacobi Capital Management LLC.

PBUS stock was purchased by a variety of institutional investors in the last quarter, including National Pension Service, and AdvisorNet Financial Inc.

Shares of PBUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PBUS stock can currently be purchased for approximately $43.32.